Molecular Weight: 4731.33 g/mol
BMJ 25(385):e078242 Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV et al (2017) Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials
Despite a limited focus in general on SDOH, in 2018 the first Trump administration approved North Carolinas Healthy Opportunities Pilots, allowing the state to cover certain non-medical services that target social needs, including housing, nutrition, transportation, and interpersonal relationship supports to specific and limited enrollees
Manufacturing capacity and supply scalability pose additional risks, especially during the early stages of commercialization
A 2022 study in the New England Journal of Medicine showed participants receiving semaglutide lost an average of 50+ pounds over 68 weeks, compared to 6 pounds in the placebo group
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective